GreenLight Biosciences Holdings, PBC

GreenLight Biosciences Holdings, PBC, listed under ticker ENVI, reached the public markets through its de-SPAC merger with Environmental Impact Acquisition Corp, a blank-check vehicle that completed its initial public offering in 2021. The combined company operated in the life sciences sector, developing RNA-based platforms targeting both human therapeutics and agricultural applications. By early 2023, GreenLight Biosciences had announced a wind-down of its operations following significant capital constraints, and the 8-K/A amendment filed on July 13, 2023 reflects regulatory activity during that dissolution period. The filing represents one of the company's final disclosures as an active public entity. Visit SpacDesk and sign up for full data access to explore complete filing histories, deal timelines, and SPAC analytics across thousands of transactions.